Workflow
集体诉讼
icon
搜索文档
WPP LAWSUIT ALERT: The Gross Law Firm Notifies WPP plc Investors of a Class Action Lawsuit and Upcoming Deadline
Globenewswire· 2025-10-31 03:50
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of WPP plc (NYSE: WPP). Shareholders who purchased shares of WPP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/wpp-plc-loss-submission-form/?id=174499&from=3 CLASS PERIOD: February 27, 2025 to July 8, 2025 ...
MRX LAWSUIT ALERT: The Gross Law Firm Notifies Marex Group plc Investors of a Class Action Lawsuit and Upcoming Deadline
Prnewswire· 2025-10-30 20:45
Accessibility StatementSkip Navigation NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Marex Group plc (NASDAQ: MRX). Shareholders who purchased shares of MRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/marex-group-plc-loss-submission-form/?id=174491&f ...
FLUOR CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Fluor Stockholders to Contact the Firm Regarding their Rights Before November 14th
Globenewswire· 2025-10-30 05:29
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fluor (FLR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Fluor securities between February 18, 2025 and July 31, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Ea ...
VFC CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds VF Corporation Investors to Contact the Firm Before November 11th
Globenewswire· 2025-10-30 05:23
诉讼事件概述 - 一家名为Bragar Eagel & Squire PC的律师事务所宣布 代表在2023年10月30日至2025年5月20日期间购买VFC公司证券的投资者 对VF Corporation提起了集体诉讼 [8] - 诉讼指控VFC公司高管在该期间做出了重大虚假和误导性陈述 并/或未能披露重要事实 [3] 具体指控内容 - 指控VFC公司向投资者提供了关于其业务扭转计划的过于积极的陈述 同时隐瞒了有关这些计划真实状况的重大不利事实 [3] - 具体而言 公司未能披露需要采取额外的重大重置行动才能使Vans品牌恢复增长 这导致Vans品牌的收入增长轨迹遭受重大挫折 [3] - 这些挫折并未在公司关于“Reinvent”计划或Vans品牌扭转进展的公开评论中被提及或警示 [3] - 因此 公司关于其业务 运营和前景的陈述在所有相关时间点均存在重大虚假和误导性 导致原告及其他股东以被人为抬高的价格购买了VFC证券 [3]
Portnoy Law Firm Announces Class Action on Behalf of Tronox Holdings PLC Investors
Globenewswire· 2025-10-29 01:30
LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Tronox Holdings PLC, (“Tronox” or the "Company") (NYSE: TROX) investors off a class action on behalf of investors that bought securities between February 12, 2025 and July 30, 2025, inclusive (the “Class Period”). Tronox investors have until November 3, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal ri ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NuScale Power Corporation - SMR
Prnewswire· 2025-10-28 22:00
Accessibility StatementSkip Navigation Following the downgrade, NuScale's stock price fell $9.49 per share, or 21.47%, over the following two trading sessions, to close at $34.72 per share on October 22, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc. - ALEC
Prnewswire· 2025-10-28 22:00
[Click here for information about joining the class action] On October 21, 2025, Alector issued a press release "announc[ing] results from the Phase 3 INFRONT-3 clinical trial evaluating latozinemab (AL001) in individuals with frontotemporal dementia due to a progranulin gene mutation (FTD-GRN)."Â The press release disclosed that latozinemab "did not meet the clinical co- primary endpoint of slowing FTD-GRNÂ progression," and that "the secondary and exploratory endpoints, such as fluid biomarkers and volume ...
The Gross Law Firm Notifies Semler Scientific, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SMLR
Prnewswire· 2025-10-27 20:45
Shareholders who purchased shares of SMLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. Accessibility StatementSkip Navigation NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR). CONTACT: The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: [email protec ...
SEMLER CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Semler Investors of the October 28th Deadline in the Filed Class Action Lawsuit
Globenewswire· 2025-10-26 22:26
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR) To Contact Him Directly To Discuss Their Options. If you purchased or acquired Semler Scientific securities between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 26, 2025 (GLOBE NEWSWIRE) -- What’s Happeni ...
LIFEMD CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges LifeMD Investors to Contact the Firm Before October 27th Regarding Filed Class Action
Globenewswire· 2025-10-26 22:17
诉讼核心信息 - 美国纽约东区联邦地区法院已对LifeMD公司提起集体诉讼 [7] - 诉讼代表在2025年5月7日至2025年8月5日期间购买或收购了LifeMD证券的所有个人和实体 [7] - 投资者申请成为首席原告的截止日期为2025年10月27日 [7] 指控具体内容 - 指控被告在集体诉讼期间做出了重大虚假和/或误导性陈述,和/或未能披露相关信息 [3] - 指控被告严重夸大LifeMD的竞争地位 [3] - 指控被告在提高LifeMD的2025年业绩指引时是鲁莽的,因其未恰当核算RexMD业务部门不断上升的客户获取成本,以及与销售 Wegovy 和 Zepbound 等肥胖治疗药物相关的客户获取成本 [3] - 指控因此被告关于LifeMD业务、运营和前景的陈述在所有时间点均存在重大虚假误导和/或缺乏合理依据 [3]